Keros Therapeutics Inc. (KROS)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
11. 07
-0.01
-0.0903%
After Hours
$
+0.41 +3.7037% 11. 48
354.54M Market Cap
- P/E Ratio
- Div Yield
96,238 Volume
-5.27 Eps
$ 11.08
Previous Close 
Want to track KROS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.01 | 3.62 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
KROS Earnings Reports FAQ
What is the earnings per share (EPS) for KROS?
The current EPS is -5.27.
What is the company's earnings growth rate?
Keros Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Keros Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Keros Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KROS at this time, as Keros Therapeutics Inc has no recent EPS data to calculate it.
